Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor.

British Journal of Pharmacology
Peter KanellakisAlexander Bobik

Abstract

Darbepoetin, a long-acting erythropoietin derivative, attenuates cardiomyocyte apoptosis and improves short-term (3 days) cardiac function, but the mechanisms responsible are unknown. We investigated potential mechanisms by which darbepoetin exerts cardioprotection following myocardial infarction in mice and the significance of the erythropoietin receptor (EPOR)-common beta-chain (c-beta-chain) heteroreceptor. Mice underwent 60 min coronary occlusion followed by treatment with vehicle or a single dose of darbepoetin. Effects on gene expression, apoptosis and neutrophil accumulation in infarcted left ventricle were assessed 24 h later. Cardiac function, effects on vascularization and fibrosis were assessed 28 days later. The significance of EPOR-c-beta-chain heteroreceptor was examined 28 days after infarction using mice deficient in c-beta-chain. Twenty-four hours after darbepoetin, mRNAs encoding haeme oxygenase-1 (HO-1), iNOS and brain natriuretic peptide (BNP) were markedly elevated only in infarcted regions, and the frequency of apoptotic cells attenuated. Inflammation was also attenuated with reductions in neutrophil numbers. Darbepoetin also elevated mRNAs encoding angiogenic factors: placental growth factor, monocyte che...Continue Reading

References

Mar 6, 1999·The Journal of Biological Chemistry·L RössigS Dimmeler
May 14, 1999·Trends in Endocrinology and Metabolism : TEM·S N ConstantinescuH F Lodish
Mar 29, 2000·Proceedings of the National Academy of Sciences of the United States of America·N TamuraM Katsuki
Sep 3, 2002·Microvascular Research·Kai JaquetKarl-Heinz Kuck
Jan 11, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Savio P D'SouzaGary F Baxter
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chul Woo YangByung Kee Bang
Jan 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Roberto BianchiPietro Ghezzi
Feb 14, 2004·Cardiovascular Research·Jakob Vinten-Johansen
Aug 17, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Hajime FujimotoRyozo Nagai
Oct 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael BrinesAnthony Cerami
Jan 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·Fabio FiordalisoRoberto Latini
Jan 29, 2005·Journal of Cardiovascular Pharmacology and Therapeutics·Ernst R SchwarzBarry F Uretsky
Mar 26, 2005·Stroke; a Journal of Cerebral Circulation·Ludmila BelayevMyron D Ginsberg
Jun 11, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Paul R HanlonElizabeth Murphy
Nov 18, 2005·Journal of Molecular and Cellular Cardiology·Steven P Jones, Roberto Bolli
Feb 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xiaoli LiuLuis G Melo
May 20, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Tina RajAlex Agrotis
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Antonella NaldiniMarco Presta
Mar 27, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Erhe GaoWalter J Koch
Jun 20, 2007·Journal of Cardiovascular Pharmacology·John E BakerGarrett J Gross
Jun 29, 2007·Journal of Molecular and Cellular Cardiology·Catalin TomaPeter J Counihan
Nov 21, 2007·The Journal of Experimental Medicine·Matthias NahrendorfMikael J Pittet
Jun 7, 2008·Journal of Molecular and Cellular Cardiology·Heng-Huei LinLee-Young Chau
Mar 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marzia LeidiJosée Golay

❮ Previous
Next ❯

Citations

Jan 15, 2013·Cardiovascular Drugs and Therapy·Takao YanagawaYoshifusa Aizawa
Jan 29, 2011·The Journal of Pharmacology and Experimental Therapeutics·Leela CherianClaudia Robertson
Dec 21, 2011·Molecular Medicine·Michael Brines, Anthony Cerami
Nov 3, 2010·Haematologica·Murat O Arcasoy
Nov 14, 2013·Expert Review of Cardiovascular Therapy·François RoubilleJean-Claude Tardif
Aug 25, 2012·Expert Opinion on Drug Safety·Lucia Del Vecchio, Francesco Locatelli
Oct 13, 2012·The International Journal of Neuroscience·Pinar SeymenHakki Oktay Seymen
Jan 13, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Edward J Calabrese
Jan 26, 2013·International Journal of Molecular Sciences·Maria Letizia TrincavelliClaudia Martini
Jul 26, 2011·Journal of Hypertension·Peter KanellakisAlexander Bobik
Aug 24, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Willem G van RijtHenri G D Leuvenink
Feb 11, 2020·Frontiers in Physiology·Sukanya SureshConstance T Noguchi
Aug 22, 2018·Scientific Reports·Karen S Cheung Tung ShingUrmi Dhagat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis